A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)
Clinical trial NCT05919693 · COMPLETED
Trial details
- NCT number
- NCT05919693
- Sponsor
- EyeBiotech Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2024-08-26
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.